Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Roche”

Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal CarcinomaCompleted
NCT02120911Phase 1, Phase 2Updated Jul 1, 2020
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Esophageal Carcinoma
Netherlands
A Pragmatic Trial of Corticosteroid Optimisation in Severe AsthmaCompleted
NCT02717689NAUpdated Jun 25, 2020
Sponsor: Belfast Health and Social Care Trust
Severe Persistent Asthma
United Kingdom
A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCLCompleted
NCT02055820Phase 1, Phase 2Updated Jun 11, 2020
Sponsor: Hoffmann-La Roche
Lymphoma, Non-Hodgkin
United States, Australia, Austria, Canada, Czechia +5 more
Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop ControlCompleted
NCT02679287NAUpdated Jun 9, 2020
Sponsor: University of Virginia
Diabetes Mellitus, Type 1
United States
Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care WorkersUnknown
NCT04387890N/AUpdated May 28, 2020
Sponsor: Hospital Italiano de Buenos Aires
COVID-19 · SARS-CoV 2 · Health Personnel
A 2 Part Study to Assess the Relative Bioavailability of Tablet Formulation Compared to Capsule Formulation and the Effect of Food and Taste Assessment on the Tablet Formulation in Healthy ParticipantsCompleted
NCT03847987Phase 1Updated May 28, 2020
Sponsor: Hoffmann-La Roche
Healthy Volunteers
United States
A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) ParticipantsTerminated
NCT02624986Phase 1, Phase 2Updated May 18, 2020
Sponsor: Hoffmann-La Roche
Non-Hodgkin's Lymphoma
United States, Australia, Germany, New Zealand, South Korea
A Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical PracticeCompleted
NCT03291457N/AUpdated May 18, 2020
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Belgium
A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid TumorsCompleted
NCT02174172Phase 1Updated May 12, 2020
Sponsor: Hoffmann-La Roche
Solid Cancers
United States, Netherlands
Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard TreatmentCompleted
NCT00006164Phase 3Updated May 12, 2020
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Chronic Hepatitis c · Cirrhosis, Liver · Fibrosis, Liver · Hepatic Cirrhosis
United States
A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RO7017773 in Healthy ParticipantsCompleted
NCT03774576Phase 1Updated May 7, 2020
Sponsor: Hoffmann-La Roche
Healthy Volunteers
France
Spanish Registry of Mohs SurgeryCompleted
NCT02310503N/AUpdated May 5, 2020
Sponsor: Fundación Academia Española de Dermatología
Skin Neoplasms · Carcinoma, Basal Cell · Carcinoma, Squamous Cell · Dermatofibrosarcoma
Spain
Non-Invasive Chromosomal Evaluation of 22q11.2Completed
NCT02541058N/AUpdated Apr 30, 2020
Sponsor: Cindy Cisneros
22q.11.2 Deletion/Duplication
Belgium
Development of a Prenatal Test for Fetal Aneuploidy DetectionCompleted
NCT01451671N/AUpdated Apr 30, 2020
Sponsor: Cindy Cisneros
Fetal Complications
United States
Non-Invasive Chromosomal Evaluation of Trisomy StudyCompleted
NCT02201862N/AUpdated Apr 30, 2020
Sponsor: Cindy Cisneros
Aneuploidy · Trisomy 21 · Trisomy 18 · Trisomy 13
United States
Development of a Non-invasive Prenatal TestCompleted
NCT01451684N/AUpdated Apr 30, 2020
Sponsor: Cindy Cisneros
Pregnancy
United States
Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants With Influenza-Like SymptomsCompleted
NCT03629184Phase 3Updated Apr 29, 2020
Sponsor: Hoffmann-La Roche
Influenza
United States, Costa Rica, Israel, Mexico, Poland +2 more
The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial PancreasCompleted
NCT03563313NAUpdated Apr 28, 2020
Sponsor: University of Virginia
Type 1 Diabetes Mellitus
United States
A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS)Completed
NCT02145026Phase 4Updated Apr 24, 2020
Sponsor: Hoffmann-La Roche
Myelodysplastic Syndromes
Thailand
A Study of Decreased Dose Frequency in Participants With Systemic Juvenile Arthritis Who Experience Laboratory Abnormalities During Treatment With RoActemra/Actemra (Tocilizumab)Completed
NCT01734382Phase 4Updated Apr 24, 2020
Sponsor: Hoffmann-La Roche
Juvenile Idiopathic Arthritis
United States, Argentina, Canada, Germany, Israel +5 more
A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC)Completed
NCT02013219Phase 1Updated Apr 21, 2020
Sponsor: Hoffmann-La Roche
Non-Small Cell Lung Cancer
United States, France, Hong Kong, South Korea, Spain +1 more
Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in ArgentinaCompleted
NCT03059251N/AUpdated Apr 17, 2020
Sponsor: Hoffmann-La Roche
Chronic Lymphocytic Leukemia
Argentina
A Study of RO6958688 in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen Positive Solid TumorsCompleted
NCT02324257Phase 1Updated Apr 17, 2020
Sponsor: Hoffmann-La Roche
Solid Tumors
United States, Canada, Denmark, France, Italy +2 more
STI571 ProspectIve RandomIzed Trial: SPIRITCompleted
NCT00219739Phase 3Updated Apr 13, 2020
Sponsor: Poitiers University Hospital
Chronic Myeloid Leukemia
France
Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal AdenocarcinomaTerminated
NCT00353457Phase 2Updated Apr 9, 2020
Sponsor: Abramson Cancer Center at Penn Medicine
Rectal Cancer

Previous page Next page